2024
|
Invention
|
Peptide exchange system and method.
The methods disclosed in the present disclosure allow quanti... |
2023
|
Invention
|
Protein collection determination system, protein collection determination method, and recording m... |
2022
|
P/S
|
Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immu... |
|
Invention
|
T cell epitope peptide derived from sars-cov-2. An antigen peptide which contains at least five c... |
|
Invention
|
Anti-her2 antibody and pharmaceutical composition containing same. Provided is a non-cardiotoxic ... |
2020
|
Invention
|
Mhc class ii molecule-based peptide exchange system and method.
The present disclosure relates t... |
|
P/S
|
Reagents for use in medical genetic testing; diagnostic
reagents for medical use; reagents for m... |
|
Invention
|
Prognosis prediction method of idiopathic pulmonary fibrosis.
A method for determining a prognos... |
|
Invention
|
Prognosis prediction method of idiopathic pulmonary fibrosis. This method for determining the pro... |
2018
|
Invention
|
Method using fluorescent proteins for determining interaction between proteins. This method deter... |
|
Invention
|
Method for purifying mesenchymal stem cells to improve transplantation efficiency. A method for p... |
2017
|
P/S
|
Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; ... |
|
P/S
|
Chemical substances for analyses in laboratories, other than
for medical or veterinary purposes;... |
|
Invention
|
Peptide exchange system and method. The methods and kits disclosed in the present disclosure allo... |
2016
|
Invention
|
Hla-a11 restrictive cytotoxic t cell epitope peptide. The objective of the present invention is t... |
|
Invention
|
Method for detecting protein-protein interaction. determining an interaction between the first pr... |
2015
|
Invention
|
Tumor antigen peptide. The object is to provide a tumor antigen peptide that is specifically pres... |
|
Invention
|
Tumor antigen peptides. The purpose of the present invention is to provide: a tumor antigen pepti... |
|
Invention
|
Method for judging protein interaction. A method for judging the interaction between a first pro... |
|
Invention
|
Antibody having infection-inhibiting activity against hepatitis c virus.
An anti-hepatitis C vir... |
|
Invention
|
Antibody having infection-inhibiting activity against hepatitis c virus. The present invention p... |
2014
|
Invention
|
Antinuclear antibody image analysis system, antinuclear antibody image analysis method, and antin... |
|
Invention
|
Antibody having broad neutralization activity against group 1 influenza a viruses.
From PBMCs of... |
|
Invention
|
Antibody having broad neutralizing activity in group 1 influenza a virus. From PBMCs originating... |
|
Invention
|
Functional monoclonal antibody against heparin-binding epidermal growth factor-like growth factor... |
|
Invention
|
Antibody against human nrg1 protein. An object is to provide an antibody capable of specifically ... |
|
Invention
|
Antibodies to human nrg1 protein. The present invention addresses the problem of providing antibo... |
2013
|
Invention
|
Method for preparation of antigen-specific cytotoxic t lymphocytes.
The invention is intended to... |
|
Invention
|
T cell receptor and uses thereof. A method has been developed to efficiently proliferate and cult... |
|
Invention
|
Monoclonal antibody against human midkine. A monoclonal antibody, which recognizes at least two a... |
|
Invention
|
Monoclonal antibody against human midkine. It is found that a monoclonal antibody capable of reco... |
|
Invention
|
Anti-cxadr antibody. An object is to find a target molecule effective for cancer treatments and t... |
|
Invention
|
Anti-cxadr antibody. In order to provide an antibody that can detect a target molecules useful f... |
2012
|
Invention
|
Method for detecting protein-protein interaction. A method for detecting interaction between a fi... |
|
Invention
|
Molecular marker for the early detection of malignant pleural mesothelioma and the methods of its... |
|
Invention
|
Molecular marker for early indentification of pleural mesothelioma patients, and expression analy... |
|
Invention
|
Monoclonal antibody for human telomerase reverse transcriptase. A monoclonal antibody which binds... |
2011
|
Invention
|
Methods and composition for testing, preventing, and treating aspergillus fumigatus infection.
A... |
|
Invention
|
Method for testing for, preventing, and treating infectious disease aspergillus fumigatus; and co... |
|
Invention
|
Fluorescent protein. Montipora. sp. |
|
Invention
|
Antibody being capable of binding to transforming growth factor alpha and having growth-suppressi... |
|
Invention
|
Antibody capable of binding to transforming growth factor alpha and having antiproliferative acti... |
|
Invention
|
Fluorescent protein and chromoprotein. Actinia equine. |
|
Invention
|
Esophageal cancer marker. As a result of immunohistochemical staining of human cancer pathologica... |
2010
|
Invention
|
Fluorescent protein and chromoprotein. Scolymia vitiensis, which have certain fluorescent property. |
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations;
reagents for medical use; reagents for dia... |
2009
|
Invention
|
Kit for preparation of antigen-specific cytotoxic lymphocytes.
The invention is intended to furt... |
|
Invention
|
Anti-human clcp1 antibody and use thereof. The present invention provides novel antibodies that r... |
|
Invention
|
Diagnostic kit for solid cancer and medicament for solid cancer therapy.
The present invention p... |
|
Invention
|
Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibo... |
2007
|
Invention
|
Antibody having enhanced adcc activity and method for production thereof.
Disclosed is an antibo... |
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations;
medicines for human purposes; drugs for me... |
2006
|
P/S
|
Chemical reagents other than for medical purposes, reagents for biochemical basic research purpos... |
2004
|
P/S
|
Proteins and protein based kits comprised of buffers, controls, substrates and other chemical rea... |
2003
|
Invention
|
Antibody library. An antibody library is prepared by selecting a light chain variable region capa... |
2002
|
P/S
|
Proteins and protein based kits comprised of buffers, controls, substrates, and other chemical re... |